BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Tech for Efficiency: Applications and Apparatuses to Accomplish More - 2Illegal entries into Germany halve over two years, border police say
- 3West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- 4Productive CRM Programming for Client Relationship The executives
- 5Vote in favor of your Favored Travel Movement
- 6 Arranging Administrations to Change Your Open air Space
- Home Security Frameworks with Shrewd Elements
- NASA satellite gazes into Medusa Pool | Space photo of the day for Dec. 24, 2025
- Step by step instructions to Protect Your Retirement with Senior Protection.
- EU delegation urges China to tighten export controls
- Why are NASA's Artemis astronauts wearing orange? What are they bringing to space? What to know about the preparation for their moon mission.
- McDonald's is bringing two 'KPop Demon Hunters' meals to McDonald's. Here's what they include and when they launch.
- Charli xcx recorded original songs for 'Wuthering Heights' — what to know about the new album for Margot Robbie's film
- Benihana is 60 years old. Gen Z is lining up.
